当前的诊断和治疗方法 艰难的 Clostridioides 感染
1Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. bellaaabellss@gmail.com.
Acta medica Indonesiana
|July 31, 2023
概括
困难杆菌感染具有广泛的疾病严重程度. 由于治疗选择有限和诊断挑战,预防在印度尼西亚是关键.
科学领域:
- 传染性疾病 传染性疾病
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 艰难杆菌感染 (CDI) 涵盖了一系列的胃肠道疾病,从轻微的腹到严重的疾病,如有毒的大结肠.
- 对CDI存在诊断挑战,需要涉及GDH或NAAT和毒素确认的特定测试协议.
- 印度尼西亚CDI治疗选择有限,需要专注于预防策略.
研究的目的:
- 总结Clostridioides difficile感染的临床谱和诊断考虑因素.
- 在印尼背景下突出CDI诊断和治疗的挑战.
- 强调印度尼西亚CDI预防策略的重要性.
主要方法:
- 关于C. difficile感染流行病学,诊断和治疗的文献综述.
- 对C. difficile感染的诊断标准的分析.
- 对印度尼西亚相关的当前治疗指南和预防措施的审查.
主要成果:
- CDI呈现的严重程度各不相同,包括自限性腹和暴发性结肠炎.
- 准确的CDI诊断依赖于高风险患者的临床怀疑和特定的实验室测试 (GDH/NAAT以及毒素检测) 的结合.
- 印尼缺乏有效的治疗方法,这凸显了感染控制的关键作用.
结论:
- 通过标准预防措施和明智的抗生素使用,有效预防C. difficile感染在印度尼西亚至关重要.
- 解决诊断复杂性和有限的治疗可用性对于管理CDI至关重要.
- 需要进一步的研究和资源配置,以改善印尼的CDI结果.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
355
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
355
Drugs for Treatment of Diarrhea-Predominant IBS
214
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
214
Differential Staining Technique
74
Differential staining is an essential microbiological technique that exploits variations in cell wall structures to classify and identify microorganisms. It facilitates the distinction of bacteria, aiding in diagnostic and research applications. Two of the most widely used differential staining methods are Gram staining and acid-fast staining, both of which rely on the chemical and structural differences in bacterial cell walls.Gram Staining TechniqueGram staining differentiates bacteria by...
74
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
192
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
192
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195


